These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. Ashkenazi S, Passwell JH, Harlev E, Miron D, Dagan R, Farzan N, Ramon R, Majadly F, Bryla DA, Karpas AB, Robbins JB, Schneerson R. J Infect Dis; 1999 Jun 15; 179(6):1565-8. PubMed ID: 10228084 [Abstract] [Full Text] [Related]
7. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity. Jennison AV, Roberts F, Verma NK. FEMS Immunol Med Microbiol; 2006 Apr 15; 46(3):444-51. PubMed ID: 16553820 [Abstract] [Full Text] [Related]
8. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Passwell JH, Ashkenazi S, Harlev E, Miron D, Ramon R, Farzam N, Lerner-Geva L, Levi Y, Chu C, Shiloach J, Robbins JB, Schneerson R, Israel Shigella Study Group. Pediatr Infect Dis J; 2003 Aug 15; 22(8):701-6. PubMed ID: 12913770 [Abstract] [Full Text] [Related]
9. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei. Rui X, Xu Y, Wan H, Su G, Huang C. Chin J Biotechnol; 1996 Aug 15; 12(2):89-97. PubMed ID: 8988355 [Abstract] [Full Text] [Related]
10. Characterization of five Shigella flexneri variant Y-specific monoclonal antibodies using defined saccharides and glycoconjugate antigens. Carlin NI, Bundle DR, Lindberg AA. J Immunol; 1987 Jun 15; 138(12):4419-27. PubMed ID: 2438343 [Abstract] [Full Text] [Related]
16. Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a. Theillet FX, Saul FA, Vulliez-Le Normand B, Hoos S, Felici F, Weintraub A, Mulard LA, Phalipon A, Delepierre M, Bentley GA. J Mol Biol; 2009 May 15; 388(4):839-50. PubMed ID: 19328810 [Abstract] [Full Text] [Related]
17. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Wright K, Guerreiro C, Laurent I, Baleux F, Mulard LA. Org Biomol Chem; 2004 May 21; 2(10):1518-27. PubMed ID: 15136809 [Abstract] [Full Text] [Related]
18. Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit. Bélot F, Wright K, Costachel C, Phalipon A, Mulard LA. J Org Chem; 2004 Feb 20; 69(4):1060-74. PubMed ID: 14961653 [Abstract] [Full Text] [Related]
19. Outer Membrane Vesicles Derived from Salmonella enterica Serotype Typhimurium Can Deliver Shigella flexneri 2a O-Polysaccharide Antigen To Prevent Shigella flexneri 2a Infection in Mice. Tian H, Li B, Xu T, Yu H, Chen J, Yu H, Li S, Zeng L, Huang X, Liu Q. Appl Environ Microbiol; 2021 Sep 10; 87(19):e0096821. PubMed ID: 34319809 [Abstract] [Full Text] [Related]
20. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Oaks EV, Turbyfill KR. Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]